Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

[Rare hereditary tumours].

Nagy P, Lahm E, Pápai Z.

Magy Onkol. 2014 Jun;58(2):94-7. Epub 2013 Nov 10. Hungarian.

PMID:
25010757
[PubMed - in process]
Free Article
2.

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.

André F, O'Regan R, Ozguroglu M, Toi M, Xu B, Jerusalem G, Masuda N, Wilks S, Arena F, Isaacs C, Yap YS, Papai Z, Lang I, Armstrong A, Lerzo G, White M, Shen K, Litton J, Chen D, Zhang Y, Ali S, Taran T, Gianni L.

Lancet Oncol. 2014 May;15(6):580-91. doi: 10.1016/S1470-2045(14)70138-X. Epub 2014 Apr 14.

PMID:
24742739
[PubMed - indexed for MEDLINE]
3.

[Medical treatment of soft tissue sarcomas based on the histological subtype].

Pápai Z.

Magy Onkol. 2014 Mar;58(1):53-8. Epub 2014 Feb 1. Review. Hungarian.

PMID:
24712007
[PubMed - indexed for MEDLINE]
Free Article
4.

[Surgical treatment of retroperitoneal sarcomas].

Bursics A, Besznyák I, Mersich T, Pörneczi B, Dede K, Papp G, Ágoston P, Pápai Z.

Magy Onkol. 2014 Mar;58(1):47-51. Epub 2014 Feb 12. Review. Hungarian.

PMID:
24712006
[PubMed - indexed for MEDLINE]
Free Article
5.

[Resection and reconstruction in cases of musculosceletal soft tissue sarcomas].

Antal I, Kiss J, Perlaky T, Szalay K, Vancsó P, Oláh Z, Sápi Z, Pápai Z, Szendrői M.

Magy Onkol. 2014 Mar;58(1):32-6. Epub 2014 Mar 1. Review. Hungarian.

PMID:
24712004
[PubMed - indexed for MEDLINE]
Free Article
6.

Mass spectrometric identification of ancient proteins as potential molecular biomarkers for a 2000-year-old osteogenic sarcoma.

Bona A, Papai Z, Maasz G, Toth GA, Jambor E, Schmidt J, Toth C, Farkas C, Mark L.

PLoS One. 2014 Jan 27;9(1):e87215. doi: 10.1371/journal.pone.0087215. eCollection 2014.

PMID:
24475253
[PubMed - in process]
Free PMC Article
7.

[Treatment of metastatic midgut neuroendocrine tumour associated with carcinoid syndrome].

Uhlyarik A, Lahm E, Vachaja J, Pápai Z.

Orv Hetil. 2014 Feb 1;155(5):194-8. doi: 10.1556/OH.2014.29818. Hungarian.

PMID:
24463166
[PubMed - in process]
8.

[Our experience with targeted therapy in glioblastoma multiforme].

Kiss E, Lahm E, Vachaja J, Nagy P, Bazsó P, Fekete Z, Takácsi-Nagy Z, Pápai Z.

Magy Onkol. 2013 Dec;57(4):264-8. doi: MagyOnkol.2013.57.4.264. Epub 2013 Nov 1. Hungarian.

PMID:
24353992
[PubMed - indexed for MEDLINE]
Free Article
9.

[Diagnosis and treatment options of neuroendocrine tumours].

Uhlyarik A, Pápai Z.

Orv Hetil. 2013 Sep 29;154(39):1549-55. doi: 10.1556/OH.2013.29716. Review. Hungarian.

PMID:
24058100
[PubMed - indexed for MEDLINE]
10.

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).

Changchien YC, Tátrai P, Papp G, Sápi J, Fónyad L, Szendrői M, Pápai Z, Sápi Z.

J Transl Med. 2012 Oct 30;10:216. doi: 10.1186/1479-5876-10-216.

PMID:
23110793
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.

Modest DP, Brodowicz T, Stintzing S, Jung A, Neumann J, Laubender RP, Ocvirk J, Kurteva G, Papai Z, Knittelfelder R, Kirchner T, Heinemann V, Zielinski CC.

Oncology. 2012;83(5):241-7. Epub 2012 Aug 29.

PMID:
22948721
[PubMed - indexed for MEDLINE]
12.

Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.

Scagliotti GV, Krzakowski M, Szczesna A, Strausz J, Makhson A, Reck M, Wierzbicki RF, Albert I, Thomas M, Miziara JE, Papai ZS, Karaseva N, Thongprasert S, Portulas ED, von Pawel J, Zhang K, Selaru P, Tye L, Chao RC, Govindan R.

J Clin Oncol. 2012 Jun 10;30(17):2070-8. doi: 10.1200/JCO.2011.39.2993. Epub 2012 May 7.

PMID:
22564989
[PubMed - indexed for MEDLINE]
Free Article
13.

Correlation between DNA ploidy, metaphase high-resolution comparative genomic hybridization results and clinical outcome of synovial sarcoma.

Balogh Z, Szemlaky Z, Szendroi M, Antal I, Pápai Z, Fónyad L, Papp G, Changchien YC, Sápi Z.

Diagn Pathol. 2011 Nov 3;6:107. doi: 10.1186/1746-1596-6-107.

PMID:
22053830
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

Quoix E, Ramlau R, Westeel V, Papai Z, Madroszyk A, Riviere A, Koralewski P, Breton JL, Stoelben E, Braun D, Debieuvre D, Lena H, Buyse M, Chenard MP, Acres B, Lacoste G, Bastien B, Tavernaro A, Bizouarne N, Bonnefoy JY, Limacher JM.

Lancet Oncol. 2011 Nov;12(12):1125-33. doi: 10.1016/S1470-2045(11)70259-5. Epub 2011 Oct 21.

PMID:
22019520
[PubMed - indexed for MEDLINE]
15.

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).

Pritchard KI, Rolski J, Papai Z, Mauriac L, Cardoso F, Chang J, Panasci L, Ianuli C, Kahan Z, Fukase K, Lindemann JP, Macpherson MP, Neven P.

Breast Cancer Res Treat. 2010 Sep;123(2):453-61. doi: 10.1007/s10549-010-1022-9. Epub 2010 Jul 15.

PMID:
20632084
[PubMed - indexed for MEDLINE]
16.

Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial.

Ocvirk J, Brodowicz T, Wrba F, Ciuleanu TE, Kurteva G, Beslija S, Koza I, Pápai Z, Messinger D, Yilmaz U, Faluhelyi Z, Yalcin S, Papamichael D, Wenczl M, Mrsic-Krmpotic Z, Shacham-Shmueli E, Vrbanec D, Esser R, Scheithauer W, Zielinski CC.

World J Gastroenterol. 2010 Jul 7;16(25):3133-43.

PMID:
20593498
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Metachronous metastasis from rectal adenocarcinoma to the penis--case report].

Küronya Z, Bodrogi I, Lövey J, Plótár V, Manninger S, Pápai Z.

Magy Onkol. 2009 Sep;53(3):263-6. doi: 10.1556/MOnkol.53.2009.3.5. Hungarian.

PMID:
19793691
[PubMed - indexed for MEDLINE]
Free Article
18.

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).

Sleijfer S, Ray-Coquard I, Papai Z, Le Cesne A, Scurr M, Schöffski P, Collin F, Pandite L, Marreaud S, De Brauwer A, van Glabbeke M, Verweij J, Blay JY.

J Clin Oncol. 2009 Jul 1;27(19):3126-32. doi: 10.1200/JCO.2008.21.3223. Epub 2009 May 18.

PMID:
19451427
[PubMed - indexed for MEDLINE]
Free Article
19.

Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

J Clin Oncol. 2007 Jul 20;25(21):3144-50.

PMID:
17634494
[PubMed - indexed for MEDLINE]
Free Article
20.

Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.

Eckardt JR, von Pawel J, Pujol JL, Papai Z, Quoix E, Ardizzoni A, Poulin R, Preston AJ, Dane G, Ross G.

J Clin Oncol. 2007 May 20;25(15):2086-92. Erratum in: J Clin Oncol. 2007 Aug 1;25(22):3387..

PMID:
17513814
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk